T Ohno

Summary

Country: Japan

Publications

  1. ncbi Investigation of new cytogenetic biomarkers specific to high-LET radiation using in vivo and in vitro exposed human lymphocytes
    R Kanda
    Radiation Center for Radiation Protection, National Institute of Radiological Sciences, Anagawa, Chiba, Japan kanda_r_nirs go jp
    Int J Radiat Biol 82:483-91. 2006
  2. ncbi Mucinous adenocarcinoma of Bartholin gland treated with radiation therapy: a case report
    T Ohno
    Division of Radiation Medicine, National Institute of Radiological Sciences, NIRS, Chiba, Japan
    Jpn J Clin Oncol 31:226-30. 2001
  3. ncbi Endobronchial metastasis of breast cancer 5 years after breast-conserving therapy
    T Ohno
    Department of Radiology, Takasaki National Hospital, 36 Takamatsu cho, Takasaki 370 0829, Japan
    Int J Clin Oncol 6:101-4. 2001
  4. ncbi Oxygenated and reoxygenated tumors show better local control in radiation therapy for cervical cancer
    Y Suzuki
    Research Center Hospital of Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan
    Int J Gynecol Cancer 16:306-11. 2006
  5. ncbi Flow cytometric and Ki-67 immunohistochemical analysis of cell cycle distribution of cervical cancer during radiation therapy
    K H Higuchi
    Division of Radiation Medicine, National Institute of Radiological Sciences, Chiba-shi, Japan
    Anticancer Res 21:2511-8. 2001
  6. ncbi Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy
    Y Niibe
    Division of Radiation Medicine, National Institute of Radiological Sciences, Chiba, Japan
    Int J Gynecol Cancer 13:849-55. 2003
  7. ncbi Carbon ion radiotherapy for vaginal malignant melanoma: a case report
    T Ohno
    Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan
    Int J Gynecol Cancer 17:1163-6. 2007
  8. ncbi Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study G
    K Itoh
    Division of Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Leuk Lymphoma 38:521-32. 2000

Detail Information

Publications8

  1. ncbi Investigation of new cytogenetic biomarkers specific to high-LET radiation using in vivo and in vitro exposed human lymphocytes
    R Kanda
    Radiation Center for Radiation Protection, National Institute of Radiological Sciences, Anagawa, Chiba, Japan kanda_r_nirs go jp
    Int J Radiat Biol 82:483-91. 2006
    ..To find detectable cytogenetic biomarkers that can offer information about the radiation quality of in vivo exposure retrospectively...
  2. ncbi Mucinous adenocarcinoma of Bartholin gland treated with radiation therapy: a case report
    T Ohno
    Division of Radiation Medicine, National Institute of Radiological Sciences, NIRS, Chiba, Japan
    Jpn J Clin Oncol 31:226-30. 2001
    ..Immunohistochemical study showed that mucinous adenocarcinoma of Bartholin gland produced CA19-9 and CEA...
  3. ncbi Endobronchial metastasis of breast cancer 5 years after breast-conserving therapy
    T Ohno
    Department of Radiology, Takasaki National Hospital, 36 Takamatsu cho, Takasaki 370 0829, Japan
    Int J Clin Oncol 6:101-4. 2001
    ..The measurement of hormone receptor was informative for the diagnosis of and for selecting a therapeutic strategy for the metastatic breast cancer...
  4. ncbi Oxygenated and reoxygenated tumors show better local control in radiation therapy for cervical cancer
    Y Suzuki
    Research Center Hospital of Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan
    Int J Gynecol Cancer 16:306-11. 2006
    ....
  5. ncbi Flow cytometric and Ki-67 immunohistochemical analysis of cell cycle distribution of cervical cancer during radiation therapy
    K H Higuchi
    Division of Radiation Medicine, National Institute of Radiological Sciences, Chiba-shi, Japan
    Anticancer Res 21:2511-8. 2001
    ....
  6. ncbi Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy
    Y Niibe
    Division of Radiation Medicine, National Institute of Radiological Sciences, Chiba, Japan
    Int J Gynecol Cancer 13:849-55. 2003
    ..024). The present study suggests that c-erbB-2/HER2 expression of cervical tumors might be a predictive parameter of prognosis after radiation therapy for PALN of very advanced uterine cervical carcinoma patients...
  7. ncbi Carbon ion radiotherapy for vaginal malignant melanoma: a case report
    T Ohno
    Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan
    Int J Gynecol Cancer 17:1163-6. 2007
    ..Carbon ion radiotherapy may be of value for vaginal malignant melanoma as a conservative approach...
  8. ncbi Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study G
    K Itoh
    Division of Hematology and Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Leuk Lymphoma 38:521-32. 2000
    ..The mobilization kinetics of circulating progenitor cells in patients with aggressive NHL is dependent on the dosage and schedule of CHOP...